4//SEC Filing
Koenig Sheldon L. 4
Accession 0001628280-25-013810
CIK 0001434868other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:02 PM ET
Size
4.9 KB
Accession
0001628280-25-013810
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-03-18$1.50/sh−13,047$19,623→ 1,571,962 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001766524
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:02 PM ET
- Size
- 4.9 KB